April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
BEST1 mutations in Japanese patients with Best vitelliform macular dystrophy
Author Affiliations & Notes
  • Satoshi Katagiri
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
    Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  • Takaaki Hayashi
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
  • Tetsuju Sekiryu
    Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan
  • Tamaki Gekka
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
  • Masakazu Akahori
    Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  • Hiroyuki Sasano
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
  • Yasuhiro Ohkuma
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
  • Takeshi Iwata
    Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  • Hiroshi Tsuneoka
    Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships Satoshi Katagiri, None; Takaaki Hayashi, None; Tetsuju Sekiryu, None; Tamaki Gekka, None; Masakazu Akahori, None; Hiroyuki Sasano, None; Yasuhiro Ohkuma, None; Takeshi Iwata, None; Hiroshi Tsuneoka, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Satoshi Katagiri, Takaaki Hayashi, Tetsuju Sekiryu, Tamaki Gekka, Masakazu Akahori, Hiroyuki Sasano, Yasuhiro Ohkuma, Takeshi Iwata, Hiroshi Tsuneoka; BEST1 mutations in Japanese patients with Best vitelliform macular dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To report BEST1 mutations in Japanese patients with Best vitelliform macular dystrophy (BVMD).

 
Methods
 

A total of 18 BVMD patients in 13 Japanese families were recruited in this study. We performed ophthalmic examinations, including decimal best-corrected visual acuity, slit-lamp biomicroscopy, dilated funduscopy, optical coherence tomography, full-field electroretinography, and electrooculography. Genomic DNA samples were obtained and analyzed for mutations in the BEST1 gene by Sanger sequencing.

 
Results
 

Twelve different BEST1 mutations were identified in the 13 BVMD probands. Ten mutations [c.4A>G (p.T2A), c.73C>T (p.R25W), c.240C>A(p.F80L), c.241G>A (p.V81M), c.584C>T (p.A195V), c.653G>A (p.R218H), c.665G>A (p.G222E), c.724G>A (p.V242M), c.910_912delGAT (p.D304del), c.918G>C (p.Q306N)] have been described in the literature, while 2 mutations [c.20g/a (p.S7N), c.1037C>A (p.P346H)] were novel. Compound heterozygous mutations (p.S7N and p.R218H) were found in one family. The phenotypes of almost all probands showed either stage of typical BVMD; fundus appearance, normal ERG, and abnormal EOG. Only one patient with the p.A195V mutation showed decreased ERG.

 
Conclusions
 

Twelve mutations in the BEST1 gene were identified in the 13 families with BVMD and 2 (p.S7N and p.P346H) of those mutations were novel. One patient had compound heterozygous mutations (p.S7N and p.R218H) but exhibited a typical phenotype of BVMD. Although variable BEST1 mutations were identified in this study of Japanese origin, particular frequent mutation was not found. To date, there is no report of BEST1 mutational analysis in considerable Japanese patients. Our results suggest that BEST1 mutations are largely involved in Japanese BVMD patients.

  
Keywords: 696 retinal degenerations: hereditary • 537 gene screening  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×